Usted está aquí

Inicio / 1%

Monoclonal antibody that specifically recognizes human native LDL.

Anticuerpo monoclonal que reconoce específicamente a las LDL nativas humanas.

A monoclonal antibody recognizing the oligosaccharide galactose-glucose-sialic acid N-glycolylated present in malignant tumors and the compositions containing it.

Anticuerpo monoclonal que reconoce el oligosacárido galactosa-glucosa-ácido siálico N-glicolilado presente en tumores malignos y las composiciones que lo contengan.

Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab.

Distinctions among Circulating Antibody-Secreting Cell Populations, Including B-1 Cells, in Human Adult Peripheral Blood

Seguridad y efectividad del nimotuzumab en los pacientes con tumores gliales malignos

Co-Localization of CD133/EGFR and Antiangiogenic Activity Drive the Antitumor Effect of Nimotuzumab and Radiation in Human GBM U87MG Xenografted in Mice.

DATA MINING IN THE METADATA NIMOTUZUMAB FOR DIFFERENT LOCATIONS OF CANCER

Immunological evaluation of rheumatoid arthritis patients treated with itolizumab.

Páginas

Pizarra
53-7-2717933
Dirección general
53-7-2714335
cim@cim.sld.cu
Calle 15 esq. 216 S/N, Siboney, Playa, La Habana, Cuba. A.P 16040, La Habana 11600, Cuba.
Código Postal:
11 600
Apartado Postal:
16 040